Evidence map›Paper›PMID 30774635›Full record

ReviewFrontiers in immunology2019

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines.

Aloysious Ssemaganda, Ashwini Kumar Giddam, Mehfuz Zaman, Mariusz Skwarczynski, Istvan Toth, Danielle I Stanisic, Michael F Good

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. In Vivo Evaluation of PamJournal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  2. Advances inPathogens (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aloysious SsemagandaInstitute for Glycomics, Griffith University, Southport, QLD, Australia.
Ashwini Kumar GiddamInstitute for Glycomics, Griffith University, Southport, QLD, Australia.
Mehfuz ZamanInstitute for Glycomics, Griffith University, Southport, QLD, Australia.
Mariusz SkwarczynskiSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Istvan TothSchool of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.
Danielle I StanisicInstitute for Glycomics, Griffith University, Southport, QLD, Australia.
Michael F GoodInstitute for Glycomics, Griffith University, Southport, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the development of vaccines, the ability to initiate both innate and subsequent adaptive immune responses need to be considered. Live attenuated vaccines achieve this naturally, while inactivated and sub-unit vaccines generally require additional help provided through delivery systems and/or adjuvants. Liposomes present an attractive adjuvant/delivery system for antigens. Here, we review the key aspects of immunity against

Indexed as

AnimalsHumansLiposomesMalaria VaccinesPlasmodiumLiposomesMalaria VaccinesadjuvantimmunityliposomesmalariaPlasmodiumvaccine

Identifiers

PMID30774635
PMCPMC6367261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.